128 related articles for article (PubMed ID: 26409803)
1. Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy.
Wu KY; Yang DH; Chen CW
Ann Saudi Med; 2015; 35(3):260-2. PubMed ID: 26409803
[TBL] [Abstract][Full Text] [Related]
2. Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
Constantin T; Foeldvari I; Vojinovic J; Horneff G; Burgos-Vargas R; Nikishina I; Akikusa JD; Avcin T; Chaitow J; Koskova E; Lauwerys BR; Calvo Penades I; Flato B; Gamir ML; Huppertz HI; Jaller Raad JJ; Jarosova K; Anton J; Macku M; Otero Escalante WJ; Rutkowska-Sak L; Trauzeddel R; Velez-Sanchez PJ; Wouters C; Wajdula J; Zang C; Bukowski J; Woodworth D; Vlahos B; Martini A; Ruperto N;
J Rheumatol; 2016 Apr; 43(4):816-24. PubMed ID: 26932344
[TBL] [Abstract][Full Text] [Related]
3. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
[TBL] [Abstract][Full Text] [Related]
4. Etanercept in the treatment of psoriatic arthritis.
Puig L; López-Ferrer A; Laiz A
Actas Dermosifiliogr; 2015 May; 106(4):252-9. PubMed ID: 25455504
[TBL] [Abstract][Full Text] [Related]
5. Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
Umegaki N; Kira M; Horiuchi T; Itoi S; Tani M; Yokomi A; Tanemura A; Miyahara H; Hatanaka M; Kitamura H; Kitano E; Katayama I
Mod Rheumatol; 2012 Nov; 22(6):928-30. PubMed ID: 22310967
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis after etanercept and ustekinumab treatment for psoriatic arthritis: A case report.
Nicocia G; Bonanno C; Lupica A; Toscano A; Rodolico C
Neuromuscul Disord; 2020 Mar; 30(3):246-249. PubMed ID: 32057636
[TBL] [Abstract][Full Text] [Related]
7. Ruptured septic popliteal cyst associated with psoriatic arthritis.
Tashjian RZ; Nickisch F; Dennison D
Orthopedics; 2004 Feb; 27(2):231-3. PubMed ID: 14992395
[No Abstract] [Full Text] [Related]
8. Etanercept-induced myositis: do we have to stop it? A surprising outcome.
Tariq H; Ayesha B; Weidenheim K; Franchin G
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759404
[TBL] [Abstract][Full Text] [Related]
9. Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity?
Więsik-Szewczyk E; Kucharczyk A; Świerkocka K; Rutkowska E; Jahnz-Różyk K
Clin Rheumatol; 2017 Jul; 36(7):1677-1681. PubMed ID: 28488125
[TBL] [Abstract][Full Text] [Related]
10. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.
Anandarajah AP; Schwarz EM; Totterman S; Monu J; Feng CY; Shao T; Haas-Smith SA; Ritchlin CT
Ann Rheum Dis; 2008 Mar; 67(3):296-301. PubMed ID: 17967829
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
Lubrano E; Spadaro A; Marchesoni A; Olivieri I; Scarpa R; D'Angelo S; Salvarani C; Mathieu A; Cauli A; Ferrara N; Helliwell P
Clin Exp Rheumatol; 2011; 29(1):80-4. PubMed ID: 21345296
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial.
Gladman DD; Bombardier C; Thorne C; Haraoui B; Khraishi M; Rahman P; Bensen W; Syrotuik J; Poulin-Costello M
J Rheumatol; 2011 Jul; 38(7):1355-62. PubMed ID: 21572156
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
[TBL] [Abstract][Full Text] [Related]
14. MRSA joint infection in a psoriatic patient with a coexisting respiratory infection.
Begkas D; Kouskoukis C; Katsenis D; Schoinochoritis N
Med Glas (Zenica); 2013 Feb; 10(1):171-3. PubMed ID: 23348186
[TBL] [Abstract][Full Text] [Related]
15. Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy.
Hamilton TK
J Drugs Dermatol; 2008 Nov; 7(11):1089-93. PubMed ID: 19110745
[TBL] [Abstract][Full Text] [Related]
16. Need to screen for Chagas disease and Strongyloides infestation in non-endemic countries prior to treatment with biologics.
González-Ramos J; Alonso-Pacheco ML; Mora-Rillo M; Herranz-Pinto P
Actas Dermosifiliogr; 2017 May; 108(4):373-375. PubMed ID: 28153333
[No Abstract] [Full Text] [Related]
17. The Paradoxical Induction of Crohn’s Disease Following Treatment of Psoriatic Arthritis With Etanercept.
Forouzandeh M; Vazquez T; Nouri K; Forouzandeh B
J Drugs Dermatol; 2019 Aug; 18(8):832-834. PubMed ID: 31424717
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials.
Combe B; Behrens F; McHugh N; Brock F; Kerkmann U; Kola B; Gallo G
J Rheumatol; 2016 Jun; 43(6):1063-7. PubMed ID: 27134249
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.
Di Minno MN; Iervolino S; Zincarelli C; Lupoli R; Ambrosino P; Pizzicato P; Di Minno A; Pappone N; Peluso R
Expert Opin Drug Saf; 2015; 14(12):1905-13. PubMed ID: 26618553
[TBL] [Abstract][Full Text] [Related]
20. Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept.
Gaudio A; Corrado A; Santoro N; Maruotti N; Cantatore FP
Int J Immunopathol Pharmacol; 2013; 26(1):229-33. PubMed ID: 23527726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
